{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:29:34Z","timestamp":1793276974509,"version":"4.5.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les H\u00e9patites Virales","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004100","name":"LabEx","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004100","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr HIV\/AIDS Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11904-025-00766-9","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:52:10Z","timestamp":1765961530000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Role of cccDNA in the Quest for HBV Cure- Implications for HIV-HBV Coinfection"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0700-8403","authenticated-orcid":false,"given":"Guillaume","family":"Giraud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5588-5465","authenticated-orcid":false,"given":"Barbara","family":"Testoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"key":"766_CR1","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.jhep.2025.03.018","volume":"83","author":"European Association for the Study of the Liver","year":"2025","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2025;83:502\u201383.","journal-title":"J Hepatol"},{"key":"766_CR2","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/cid\/cix747","volume":"66","author":"G-M Kouam\u00e9","year":"2018","unstructured":"Kouam\u00e9 G-M, Boyd A, Moh R, Badje A, Gabillard D, Ouattara E, et al. Higher mortality despite early antiretroviral therapy in human immunodeficiency virus and hepatitis B virus (HBV)-coinfected patients with high HBV replication. Clin Infect Dis. 2018;66:112\u201320.","journal-title":"Clin Infect Dis"},{"key":"766_CR3","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1002\/hep.31839","volume":"74","author":"HN Kim","year":"2021","unstructured":"Kim HN, Newcomb CW, Carbonari DM, Roy JA, Torgersen J, Althoff KN, et al. Risk of HCC with hepatitis B viremia among HIV\/HBV-coinfected persons in North America. Hepatology. 2021;74:1190\u2013202.","journal-title":"Hepatology"},{"key":"766_CR4","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.jhep.2021.05.013","volume":"75","author":"MG Martinez","year":"2021","unstructured":"Martinez MG, Boyd A, Combe E, Testoni B, Zoulim F. Covalently closed circular DNA: the ultimate therapeutic target for curing HBV infections. J Hepatol. 2021;75:706\u201317.","journal-title":"J Hepatol"},{"key":"766_CR5","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1097\/QAD.0000000000003193","volume":"36","author":"C Hawkins","year":"2022","unstructured":"Hawkins C, Kang M, Bhattacharya D, Cloherty G, Kuhns M, Matining R, et al. Hepatitis B surface antigen and hepatitis B RNA changes in HIV\/hepatitis B virus co-infected participants receiving hepatitis B virus-active antiretroviral therapy. AIDS. 2022;36:975\u201384.","journal-title":"AIDS"},{"key":"766_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab116","volume":"8","author":"MK Jain","year":"2021","unstructured":"Jain MK, Vigil KJ, Parisot P, Go G, Vu T, Li X, et al. Incidence and predictors of hepatitis B surface antigen clearance in HIV patients: a retrospective multisite study. Open Forum Infect Dis. 2021;8:ofab116.","journal-title":"Open Forum Infect Dis"},{"key":"766_CR7","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/QAI.0000000000002386","volume":"84","author":"J Audsley","year":"2020","unstructured":"Audsley J, Avihingsanon A, Littlejohn M, Bowden S, Matthews GV, Fairley CK, et al. Long-Term TDF-Inclusive ART and Progressive Rates of HBsAg Loss in HIV-HBV Coinfection-Lessons for Functional HBV Cure? J Acquir Immune Defic Syndr. 2020;84:527\u201333.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"766_CR8","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/S0140-6736(02)11913-1","volume":"360","author":"CL Thio","year":"2002","unstructured":"Thio CL, Seaberg EC, Skolasky R, Phair J, Visscher B, Mu\u00f1oz A, et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet. 2002;360:1921\u20136.","journal-title":"Lancet"},{"key":"766_CR9","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.3390\/v13081463","volume":"13","author":"L Wei","year":"2021","unstructured":"Wei L, Ploss A. Mechanism of hepatitis B virus CccDNA formation. Viruses. 2021;13:1463.","journal-title":"Viruses"},{"key":"766_CR10","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3390\/v16040615","volume":"16","author":"G Giraud","year":"2024","unstructured":"Giraud G, El Achi K, Zoulim F, Testoni B. Co-Transcriptional regulation of HBV replication: RNA quality also matters. Viruses. 2024;16:615.","journal-title":"Viruses"},{"key":"766_CR11","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1002\/hep.29479","volume":"66","author":"X Hong","year":"2017","unstructured":"Hong X, Kim ES, Guo H. Epigenetic regulation of hepatitis B virus covalently closed circular DNA: implications for epigenetic therapy against chronic hepatitis B. Hepatology. 2017;66:2066\u201377.","journal-title":"Hepatology"},{"key":"766_CR12","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41564-020-0678-0","volume":"5","author":"L Wei","year":"2020","unstructured":"Wei L, Ploss A. Core components of DNA lagging strand synthesis machinery are essential for hepatitis B virus CccDNA formation. Nat Microbiol. 2020;5:715\u201326.","journal-title":"Nat Microbiol"},{"key":"766_CR13","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.jhep.2018.08.012","volume":"69","author":"C Ko","year":"2018","unstructured":"Ko C, Chakraborty A, Chou W-M, Hasreiter J, Wettengel JM, Stadler D, et al. Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels. J Hepatol. 2018;69:1231\u201341.","journal-title":"J Hepatol"},{"key":"766_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100514","volume":"4","author":"T Tu","year":"2022","unstructured":"Tu T, Zehnder B, Wettengel JM, Zhang H, Coulter S, Ho V, et al. <article-title update=\"added\">Mitosis of hepatitis B virus-infected cells in\u00a0vitro results in uninfected daughter cells. JHEP Rep. 2022;4:100514.","journal-title":"JHEP Rep"},{"key":"766_CR15","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.jhep.2020.11.003","volume":"74","author":"A Suslov","year":"2021","unstructured":"Suslov A, Meier M-A, Ketterer S, Wang X, Wieland S, Heim MH. Transition to HBeAg-negative chronic hepatitis B virus infection is associated with reduced CccDNA transcriptional activity. J Hepatol. 2021;74:794\u2013800.","journal-title":"J Hepatol"},{"key":"766_CR16","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.jhep.2016.05.014","volume":"65","author":"A Boyd","year":"2016","unstructured":"Boyd A, Lacombe K, Lavocat F, Maylin S, Miailhes P, Lascoux-Combe C, et al. Decay of ccc-DNA marks persistence of intrahepatic viral DNA synthesis under tenofovir in HIV-HBV co-infected patients. J Hepatol. 2016;65:683\u201391.","journal-title":"J Hepatol"},{"key":"766_CR17","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/hep.32634","volume":"77","author":"M Lisker-Melman","year":"2023","unstructured":"Lisker-Melman M, Wahed AS, Ghany MG, Chung RT, King WC, Kleiner DE, et al. HBV transcription and translation persist despite viral suppression in HBV-HIV co-infected patients on antiretroviral therapy. Hepatology. 2023;77:594\u2013605.","journal-title":"Hepatology"},{"key":"766_CR18","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/BF01703079","volume":"8","author":"CT Bock","year":"1994","unstructured":"Bock CT, Schranz P, Schr\u00f6der CH, Zentgraf H. Hepatitis B virus genome is organized into nucleosomes in the nucleus of the infected cell. Virus Genes. 1994;8:215\u201329.","journal-title":"Virus Genes"},{"key":"766_CR19","doi-asserted-by":"publisher","first-page":"E5715","DOI":"10.1073\/pnas.1518090112","volume":"112","author":"P Tropberger","year":"2015","unstructured":"Tropberger P, Mercier A, Robinson M, Zhong W, Ganem DE, Holdorf M. Mapping of histone modifications in episomal HBV CccDNA uncovers an unusual chromatin organization amenable to epigenetic manipulation. Proc Natl Acad Sci USA. 2015;112:E5715\u20135724.","journal-title":"Proc Natl Acad Sci USA"},{"key":"766_CR20","doi-asserted-by":"crossref","unstructured":"Locatelli M, Quivy J-P, Chapus F, Michelet M, Fresquet J, Maadadi S et al. HIRA supports hepatitis B virus minichromosome establishment and transcriptional activity in infected hepatocytes. Cell Mol Gastroenterol Hepatol. 2022;S2352-345X(22)00089\u2009\u2013\u20093.","DOI":"10.1016\/j.jcmgh.2022.05.007"},{"key":"766_CR21","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1016\/j.cell.2025.01.033","volume":"188","author":"NA Prescott","year":"2025","unstructured":"Prescott NA, Biaco T, Mansisidor A, Bram Y, Rendleman J, Faulkner SC, et al. A nucleosome switch primes hepatitis B virus infection. Cell. 2025;188:2111\u20132126.e21.","journal-title":"Cell"},{"key":"766_CR22","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1002\/hep.32245","volume":"75","author":"Y Wang","year":"2022","unstructured":"Wang Y, Li Y, Zai W, Hu K, Zhu Y, Deng Q, et al. HBV covalently closed circular DNA minichromosomes in distinct epigenetic transcriptional States differ in their vulnerability to damage. Hepatology. 2022;75:1275\u201388.","journal-title":"Hepatology"},{"key":"766_CR23","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.3390\/v16101565","volume":"16","author":"A Kumar","year":"2024","unstructured":"Kumar A, Combe E, Mougen\u00e9 L, Zoulim F, Testoni B. Applications of CRISPR\/Cas as a toolbox for hepatitis B virus detection and therapeutics. Viruses. 2024;16:1565.","journal-title":"Viruses"},{"key":"766_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2024.101215","volume":"12","author":"J Ren","year":"2025","unstructured":"Ren J, Cheng S, Ren F, Gu H, Wu D, Yao X, et al. Epigenetic regulation and its therapeutic potential in hepatitis B virus covalently closed circular DNA. Genes & Diseases. 2025;12:101215.","journal-title":"Genes & Diseases"},{"key":"766_CR25","doi-asserted-by":"publisher","first-page":"19975","DOI":"10.1073\/pnas.0908365106","volume":"106","author":"L Belloni","year":"2009","unstructured":"Belloni L, Pollicino T, De Nicola F, Guerrieri F, Raffa G, Fanciulli M, et al. Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function. Proc Natl Acad Sci USA. 2009;106:19975\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"766_CR26","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.jhep.2015.06.023","volume":"63","author":"L Rivi\u00e8re","year":"2015","unstructured":"Rivi\u00e8re L, Gerossier L, Ducroux A, Dion S, Deng Q, Michel M-L, et al. HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral CccDNA involving SETDB1 histone methyltransferase. J Hepatol. 2015;63:1093\u2013102.","journal-title":"J Hepatol"},{"key":"766_CR27","doi-asserted-by":"publisher","first-page":"4663","DOI":"10.1038\/s41467-023-40225-w","volume":"14","author":"W Liu","year":"2023","unstructured":"Liu W, Yao Q, Su X, Deng Y, Yang M, Peng B, et al. Molecular insights into Spindlin1-HBx interplay and its impact on HBV transcription from CccDNA minichromosome. Nat Commun. 2023;14:4663.","journal-title":"Nat Commun"},{"key":"766_CR28","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/nature17170","volume":"531","author":"A Decorsi\u00e8re","year":"2016","unstructured":"Decorsi\u00e8re A, Mueller H, van Breugel PC, Abdul F, Gerossier L, Beran RK, et al. Hepatitis B virus X protein identifies the Smc5\/6 complex as a host restriction factor. Nature. 2016;531:386\u20139.","journal-title":"Nature"},{"key":"766_CR29","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1016\/j.celrep.2016.08.026","volume":"16","author":"CM Murphy","year":"2016","unstructured":"Murphy CM, Xu Y, Li F, Nio K, Reszka-Blanco N, Li X, et al. Hepatitis B virus X protein promotes degradation of SMC5\/6 to enhance HBV replication. Cell Rep. 2016;16:2846\u201354.","journal-title":"Cell Rep"},{"key":"766_CR30","doi-asserted-by":"publisher","first-page":"e0169648","DOI":"10.1371\/journal.pone.0169648","volume":"12","author":"C Niu","year":"2017","unstructured":"Niu C, Livingston CM, Li L, Beran RK, Daffis S, Ramakrishnan D, et al. The Smc5\/6 complex restricts HBV when localized to ND10 without inducing an innate immune response and is counteracted by the HBV X protein shortly after infection. PLoS ONE. 2017;12:e0169648.","journal-title":"PLoS ONE"},{"key":"766_CR31","doi-asserted-by":"publisher","first-page":"e0032823","DOI":"10.1128\/jvi.00328-23","volume":"97","author":"Q Yao","year":"2023","unstructured":"Yao Q, Peng B, Li C, Li X, Chen M, Zhou Z, et al. SLF2 interacts with the SMC5\/6 complex to direct hepatitis B virus episomal DNA to promyelocytic leukemia bodies for transcriptional repression. J Virol. 2023;97:e0032823.","journal-title":"J Virol"},{"key":"766_CR32","doi-asserted-by":"publisher","first-page":"11890","DOI":"10.1093\/nar\/gkaa828","volume":"48","author":"A Corpet","year":"2020","unstructured":"Corpet A, Kleijwegt C, Roubille S, Juillard F, Jacquet K, Texier P, et al. PML nuclear bodies and chromatin dynamics: catch me if you can! Nucleic Acids Res. 2020;48:11890\u2013912.","journal-title":"Nucleic Acids Res"},{"key":"766_CR33","doi-asserted-by":"publisher","first-page":"4268","DOI":"10.1038\/s41467-018-06739-4","volume":"9","author":"P Moreau","year":"2018","unstructured":"Moreau P, Cournac A, Palumbo GA, Marbouty M, Mortaza S, Thierry A, et al. Tridimensional infiltration of DNA viruses into the host genome shows Preferential contact with active chromatin. Nat Commun. 2018;9:4268.","journal-title":"Nat Commun"},{"key":"766_CR34","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3390\/v14020445","volume":"14","author":"JD Dias","year":"2022","unstructured":"Dias JD, Sarica N, Cournac A, Koszul R, Neuveut C. Crosstalk between hepatitis B virus and the 3D genome structure. Viruses. 2022;14:445.","journal-title":"Viruses"},{"key":"766_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109288","volume":"35","author":"D Tang","year":"2021","unstructured":"Tang D, Zhao H, Wu Y, Peng B, Gao Z, Sun Y, et al. Transcriptionally inactive hepatitis B virus episome DNA preferentially resides in the vicinity of chromosome 19 in 3D host genome upon infection. Cell Rep. 2021;35:109288.","journal-title":"Cell Rep"},{"key":"766_CR36","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1093\/nar\/gkad1200","volume":"52","author":"G Giraud","year":"2024","unstructured":"Giraud G, Rod\u00e0 M, Huchon P, Michelet M, Maadadi S, Jutzi D, et al. G-quadruplexes control hepatitis B virus replication by promoting cccDNA transcription and phase separation in hepatocytes. Nucleic Acids Res. 2024;52:2290\u2013305.","journal-title":"Nucleic Acids Res"},{"key":"766_CR37","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/v9010018","volume":"9","author":"Y Xia","year":"2017","unstructured":"Xia Y, Protzer U. Control of hepatitis B virus by cytokines. Viruses. 2017;9:18.","journal-title":"Viruses"},{"key":"766_CR38","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1053\/j.gastro.2006.01.001","volume":"130","author":"T Pollicino","year":"2006","unstructured":"Pollicino T, Belloni L, Raffa G, Pediconi N, Squadrito G, Raimondo G, et al. Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones. Gastroenterology. 2006;130:823\u201337.","journal-title":"Gastroenterology"},{"key":"766_CR39","doi-asserted-by":"publisher","first-page":"21097","DOI":"10.1038\/s41598-020-78001-1","volume":"10","author":"F Leboss\u00e9","year":"2020","unstructured":"Leboss\u00e9 F, Inchausp\u00e9 A, Locatelli M, Miaglia C, Diederichs A, Fresquet J, et al. Quantification and epigenetic evaluation of the residual pool of hepatitis B covalently closed circular DNA in long-term nucleoside analogue-treated patients. Sci Rep. 2020;10:21097.","journal-title":"Sci Rep"},{"key":"766_CR40","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz607","author":"A Balagopal","year":"2019","unstructured":"Balagopal A, Hwang HS, Grudda T, Quinn J, Sterling RK, Sulkowski MS, et al. Single hepatocyte hepatitis B virus transcriptional landscape in HIV co-infection. J Infect Dis. 2019. https:\/\/doi.org\/10.1093\/infdis\/jiz607.","journal-title":"J Infect Dis"},{"key":"766_CR41","doi-asserted-by":"publisher","first-page":"e140584","DOI":"10.1172\/jci.insight.140584","volume":"5","author":"A Balagopal","year":"2020","unstructured":"Balagopal A, Grudda T, Ribeiro RM, Saad YS, Hwang HS, Quinn J, et al. Single hepatocytes show persistence and transcriptional inactivity of hepatitis B. JCI Insight. 2020;5:e140584.","journal-title":"JCI Insight"},{"key":"766_CR42","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/00002030-199201000-00008","volume":"6","author":"YZ Cao","year":"1992","unstructured":"Cao YZ, Dieterich D, Thomas PA, Huang YX, Mirabile M, Ho DD. Identification and quantitation of HIV-1 in the liver of patients with AIDS. AIDS. 1992;6:65\u201370.","journal-title":"AIDS"},{"key":"766_CR43","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1128\/jvi.64.6.2553-2559.1990","volume":"64","author":"YZ Cao","year":"1990","unstructured":"Cao YZ, Friedman-Kien AE, Huang YX, Li XL, Mirabile M, Moudgil T, et al. CD4-independent, productive human immunodeficiency virus type 1 infection of hepatoma cell lines in vitro. J Virol. 1990;64:2553\u20139.","journal-title":"J Virol"},{"key":"766_CR44","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/S0168-8278(05)80579-3","volume":"19","author":"C Housset","year":"1993","unstructured":"Housset C, Lamas E, Courgnaud V, Boucher O, Girard PM, Marche C, et al. Presence of HIV-1 in human parenchymal and non-parenchymal liver cells in vivo. J Hepatol. 1993;19:252\u20138.","journal-title":"J Hepatol"},{"key":"766_CR45","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/1743-422X-9-157","volume":"9","author":"L Kong","year":"2012","unstructured":"Kong L, Cardona Maya W, Moreno-Fernandez ME, Ma G, Shata MT, Sherman KE, et al. Low-level HIV infection of hepatocytes. Virol J. 2012;9:157.","journal-title":"Virol J"},{"key":"766_CR46","doi-asserted-by":"publisher","first-page":"5860","DOI":"10.1128\/JVI.02594-09","volume":"84","author":"DM Iser","year":"2010","unstructured":"Iser DM, Warner N, Revill PA, Solomon A, Wightman F, Saleh S, et al. Coinfection of hepatic cell lines with human immunodeficiency virus and hepatitis B virus leads to an increase in intracellular hepatitis B surface antigen. J Virol. 2010;84:5860\u20137.","journal-title":"J Virol"},{"key":"766_CR47","doi-asserted-by":"publisher","first-page":"104391","DOI":"10.1016\/j.ebiom.2022.104391","volume":"87","author":"JM Zerbato","year":"2023","unstructured":"Zerbato JM, Avihingsanon A, Singh KP, Zhao W, Deleage C, Rosen E, et al. HIV DNA persists in hepatocytes in people with HIV-hepatitis B co-infection on antiretroviral therapy. EBioMedicine. 2023;87:104391.","journal-title":"EBioMedicine"},{"key":"766_CR48","doi-asserted-by":"publisher","first-page":"4728","DOI":"10.3748\/wjg.v24.i42.4728","volume":"24","author":"M Ganesan","year":"2018","unstructured":"Ganesan M, Poluektova LY, Kharbanda KK, Osna NA. Liver as a target of human immunodeficiency virus infection. World J Gastroenterol. 2018;24:4728\u201337.","journal-title":"World J Gastroenterol"},{"key":"766_CR49","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1097\/QAD.0000000000001574","volume":"31","author":"KP Singh","year":"2017","unstructured":"Singh KP, Crane M, Audsley J, Avihingsanon A, Sasadeusz J, Lewin SR. HIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment. AIDS. 2017;31:2035\u201352.","journal-title":"AIDS"},{"key":"766_CR50","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1093\/cid\/ciw380","volume":"63","author":"LI Gj\u00e6rde","year":"2016","unstructured":"Gj\u00e6rde LI, Shepherd L, Jablonowska E, Lazzarin A, Rougemont M, Darling K, et al. Trends in incidences and risk factors for hepatocellular carcinoma and other liver events in HIV and hepatitis C Virus-coinfected individuals from 2001 to 2014: A multicohort study. Clin Infect Dis. 2016;63:821\u20139.","journal-title":"Clin Infect Dis"},{"key":"766_CR51","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1093\/infdis\/jiad124","volume":"228","author":"CL Thio","year":"2023","unstructured":"Thio CL, Taddese M, Saad Y, Zambo K, Ribeiro RM, Grudda T, et al. Hepatitis B e antigen-negative single hepatocyte analysis shows transcriptional silencing and slow decay of infected cells with treatment. J Infect Dis. 2023;228:1219\u201326.","journal-title":"J Infect Dis"},{"key":"766_CR52","doi-asserted-by":"publisher","first-page":"e100067","DOI":"10.1136\/egastro-2024-100067","volume":"2","author":"A Cross","year":"2024","unstructured":"Cross A, Harris JM, Arbe-Barnes E, Nixon C, Dhairyawan R, Hall A, et al. Characterisation of HBV and co-infection with HDV and HIV through Spatial transcriptomics. eGastroenterology. 2024;2:e100067.","journal-title":"eGastroenterology"},{"key":"766_CR53","doi-asserted-by":"publisher","DOI":"10.1172\/JCI161818","volume":"132","author":"T Grudda","year":"2022","unstructured":"Grudda T, Hwang HS, Taddese M, Quinn J, Sulkowski MS, Sterling RK, et al. Integrated hepatitis B virus DNA maintains surface antigen production during antiviral treatment. J Clin Invest. 2022;132:e161818.","journal-title":"J Clin Invest"},{"key":"766_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100449","volume":"4","author":"N van Buuren","year":"2022","unstructured":"van Buuren N, Ramirez R, Soulette C, Suri V, Han D, May L, et al. Targeted long-read sequencing reveals clonally expanded HBV-associated chromosomal translocations in patients with chronic hepatitis B. JHEP Rep. 2022;4:100449.","journal-title":"JHEP Rep"},{"key":"766_CR55","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1111\/liv.14684","volume":"40","author":"K van Bremen","year":"2020","unstructured":"van Bremen K, Hoffmann C, Mauss S, Lutz T, Ingiliz P, Spinner CD, et al. Obstacles to HBV functional cure: late presentation in HIV and its impact on HBV seroconversion in HIV\/HBV coinfection. Liver Int. 2020;40:2978\u201381.","journal-title":"Liver Int"},{"key":"766_CR56","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.3390\/v13071341","volume":"13","author":"A Boyd","year":"2021","unstructured":"Boyd A, Dezanet LNC, Lacombe K. Functional cure of hepatitis B virus infection in individuals with HIV-Coinfection: A literature review. Viruses. 2021;13:1341.","journal-title":"Viruses"},{"key":"766_CR57","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/hiv.13561","volume":"25","author":"L Begr\u00e9","year":"2024","unstructured":"Begr\u00e9 L, Boyd A, Salazar-Vizcaya L, Suter-Riniker F, B\u00e9guelin C, Rockstroh JK, et al. Long-term quantitative hepatitis B surface antigen (HBsAg) trajectories in persons with and without HBsAg loss on tenofovir-containing antiretroviral therapy. HIV Med. 2024;25:291\u20138.","journal-title":"HIV Med"},{"key":"766_CR58","doi-asserted-by":"crossref","first-page":"A58","DOI":"10.1002\/hep.28391","volume":"64","author":"B Testoni","year":"2016","unstructured":"Testoni B, Berby F, Miaglia C, Lebosse F, Lampertico P, Levrero M, et al. Hepatitis B core-related antigen correlates with intrahepatic covalently closed circular DNA (cccDNA) levels and activity in untreated chronic hepatitis B (CHB) patients. Hepatology. 2016;64:A58\u20139.","journal-title":"Hepatology"},{"key":"766_CR59","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1136\/gutjnl-2023-330644","volume":"73","author":"B Testoni","year":"2024","unstructured":"Testoni B, Scholt\u00e8s C, Plissonnier M-L, Paturel A, Berby F, Facchetti F, et al. Quantification of Circulating HBV RNA expressed from intrahepatic CccDNA in untreated and NUC treated patients with chronic hepatitis B. Gut. 2024;73:659\u201367.","journal-title":"Gut"},{"key":"766_CR60","first-page":"e954","volume":"230","author":"L Begr\u00e9","year":"2024","unstructured":"Begr\u00e9 L, Boyd A, Plissonnier M-L, Testoni B, Salazar-Vizcaya L, Suter-Riniker F, et al. Circulating HBV RNA and hepatitis B Core-Related antigen trajectories in persons with HIV\/HBV coinfection and hepatitis B surface antigen loss during Tenofovir therapy. J Infect Dis. 2024;230:e954\u201363.","journal-title":"J Infect Dis"},{"key":"766_CR61","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1038\/s41590-025-02199-3","volume":"26","author":"V Venzin","year":"2025","unstructured":"Venzin V, Beccaria CG, Perucchini C, Delfino P, Bono EB, Giustini L, et al. CD4\u2009+\u2009T cells license Kupffer cells to reverse CD8\u2009+\u2009T cell dysfunction induced by hepatocellular priming. Nat Immunol. 2025;26:1352\u201366.","journal-title":"Nat Immunol"},{"key":"766_CR62","doi-asserted-by":"crossref","unstructured":"Allweiss L, Testoni B, Yu M, Lucifora J, Ko C, Qu B et al. Quantification of the hepatitis B virus cccdna: evidence-based guidelines for monitoring the key obstacle of HBV cure. Gut. 2023;gutjnl-2022-328380.","DOI":"10.1136\/gutjnl-2022-328380"},{"key":"766_CR63","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28930","volume":"95","author":"G Hogan","year":"2023","unstructured":"Hogan G, Winer BY, Ahodantin J, Sellau J, Huang T, Douam F, et al. Persistent hepatitis B virus and HIV coinfections in dually humanized mice engrafted with human liver and immune system. J Med Virol. 2023;95:e28930.","journal-title":"J Med Virol"},{"key":"766_CR64","doi-asserted-by":"crossref","unstructured":"Small Animal Models for Human Immunodeficiency Virus (HIV), Hepatitis B, and Tuberculosis: Proceedings of an NIAID Workshop. Current HIV Research. 2020;18:19\u201328.","DOI":"10.2174\/1570162X18666191223114019"},{"key":"766_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jve.2023.100344","volume":"9","author":"M Kang","year":"2023","unstructured":"Kang M, Price JC, Peters MG, Lewin SR, Sulkowski M. Design and analysis considerations for early phase clinical trials in hepatitis B (HBV) cure research: the ACTG A5394 study in persons with both HIV and HBV. J Virus Erad. 2023;9:100344.","journal-title":"J Virus Erad"},{"key":"766_CR66","doi-asserted-by":"publisher","first-page":"e100136","DOI":"10.1136\/egastro-2024-100136","volume":"2","author":"M Cocca","year":"2024","unstructured":"Cocca M, Testoni B. New dimension in viral hepatitis research. eGastroenterology. 2024;2:e100136.","journal-title":"eGastroenterology"},{"key":"766_CR67","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1136\/gutjnl-2018-317071","volume":"68","author":"US Gill","year":"2019","unstructured":"Gill US, Pallett LJ, Thomas N, Burton AR, Patel AA, Yona S, et al. Fine needle aspirates comprehensively sample intrahepatic immunity. Gut. 2019;68:1493\u2013503.","journal-title":"Gut"},{"key":"766_CR68","doi-asserted-by":"crossref","unstructured":"Testoni B, Suarez AAR, Battisti A, Plissonnier M-L, Heil M, Fontanges T et al. Evaluation of the HBV liver reservoir with fine needle aspirates. JHEPReport [Internet]. 2023 [cited 2023 Oct 10];5. Available from: https:\/\/www.jhep-reports.eu\/article\/S2589-5559(23)00172-6\/fulltext","DOI":"10.1016\/j.jhepr.2023.100841"}],"container-title":["Current HIV\/AIDS Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-025-00766-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11904-025-00766-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-025-00766-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T14:03:27Z","timestamp":1769609007000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11904-025-00766-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["766"],"URL":"https:\/\/doi.org\/10.1007\/s11904-025-00766-9","relation":{},"ISSN":["1548-3568","1548-3576"],"issn-type":[{"value":"1548-3568","type":"print"},{"value":"1548-3576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"27 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"Guillaume Giraud declares no conflict of interest. Barbara Testoni has received grants to her institution from Aligos, Assembly Biosciences, AusperBio, BlueJay Therapeutics and Imcheck.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"57"}}